Abivax Shares Plunge Amid Cancer Cases in Bowel Disease Drug Trial

Actions of Abivax It closed down 43.6% on Tuesday after reporting new data on its top asset, an ulcerative colitis…

China's rise in drug development looms over the US.

For decades, an annual meeting of oncologists has featured drug trials that were conducted primarily in American and European hospitals.…